5 hasil untuk "Amico-Ruvio, Stacy A."
Menampilkan 1–5 · 0,25 detik · RSS
-
Artikel Jurnal Teks lengkap
Stationary Gating of GluN1/GluN2B Receptors in Intact Membrane Patches
NMDA receptors are heteromeric glutamate-gated channels composed of GluN1 and GluN2 subunits. Receptor isoforms that differ in their GluN2-subunit type (A–D) are expressed differentially throughout the central nervous system and have distinct kinetic properties in recombinant systems. How specific…
-
Artikel Jurnal Teks lengkap
Ifenprodil Effects on GluN2B-Containing Glutamate Receptors
N-Methyl-d-aspartate (NMDA) receptors are glutamate- and glycine-gated channels that mediate fast excitatory transmission in the central nervous system and are critical to synaptic development, plasticity, and integration. They have a rich complement of modulatory sites, which represent important…
-
Artikel Jurnal Teks lengkap
Zinc Effects on NMDA Receptor Gating Kinetics
Zinc accumulates in the synaptic vesicles of certain glutamatergic forebrain neurons and modulates neuronal excitability and synaptic plasticity by multiple poorly understood mechanisms. Zinc directly inhibits NMDA-sensitive glutamate-gated channels by two separate mechanisms: high-affinity binding…
-
Artikel Jurnal Teks lengkap
C-terminal Domains of N-Methyl-d-aspartic Acid Receptor Modulate Unitary Channel Conductance and Gating
NMDA receptors (NRs) are glutamate-gated calcium-permeable channels that are essential for normal synaptic transmssion and contribute to neurodegeneration. Tetrameric proteins consist of two obligatory GluN1 (N1) and two GluN2 (N2) subunits, of which GluN2A (2A) and GluN2B (2B) are prevalent in…
-
Artikel Jurnal Teks lengkap
Fluoxetine modulates breast cancer metastasis to the brain in a murine model
BACKGROUND: Despite advances in the treatment of primary breast tumors, the outcome of metastatic breast cancer remains dismal. Brain metastases present a particularly difficult therapeutic target due to the “sanctuary” status of the brain, with resulting inability of most chemotherapeutic agents…